Lidocaine injections in the m. Vastus intermedius and m. Rectus femoris

The effect of lidocaine injections in the m. Vastus intermedius and m. Rectus femoris on the gait pattern in stroke patients presenting with stiff knee gait.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON20633

Enrollment

Registered

2019-09-12

Start date

2019-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Chemodenervation by lidocaine of the m. vastus intermedius and the m. rectus femoris

Eligibility

Inclusion criteria

Inclusion criteria: Age > 18 - Stroke occurred over 6 months ago - patient presents stiff knee gait - patient able to walk independently (Functional Ambulation Categories score (FAC) =3) - over activity of the m. vastus intermedius and m. rectus femoris - Patient is orientated in time, place and person and is able to understand and follow instructions

Exclusion criteria

Exclusion criteria: Existing pathologies or problems that are not caused by a CVA, that are of influence on the gait pattern - Allergy to lidocaine or other elements found in lidocaine hydrochloride - inflammation in the injection area

Design outcomes

Primary

Measure	Time frame
Knee flexion during gait	—

Secondary

Measure	Time frame
Kinetics and kinematics of the ankle, knee, hip and pelvis and BORG and VAS questionnaires on knee stability.	—

Contacts

Public ContactMartin Tenniglo

Roessingh Research and Development

m.tenniglo@rrd.nl0031880875777

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)